SCHEMBL8634231

SCHEMBL8634231

CCCCCC(CCCCC)COC=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.41
ADH1B P00325 2/20 0.39
ADH1C P00326 2/20 0.39
ADH1A P07327 2/20 0.39
ADH4 P08319 2/20 0.39
ADH7 P40394 2/20 0.39
TSHR P16473 6/20 0.39
FDPS P14324 4/20 0.39
CYP3A4 P08684 3/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TRPA1 O75762 1/20 0.38
DDAH1 O94760 1/20 0.38
GAPDH P04406 1/20 0.38
MAPT P10636 1/20 0.38
EPHX1 P07099 1/20 0.37
PRSS1 P07477 1/20 0.36
PRSS2 P07478 1/20 0.36
PRSS3 P35030 1/20 0.36
FAAH O00519 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18400778 0.98 LMNA (0.45) LMNAADH1BADH1CADH1AADH4
SCHEMBL7205361 0.98 LMNA (0.45) LMNAADH1BADH1CADH1AADH4
SCHEMBL7204584 0.98 LMNA (0.45) LMNAADH1BADH1CADH1AADH4
SCHEMBL7209541 0.98 LMNA (0.45) LMNAADH1BADH1CADH1AADH4
SCHEMBL2431569 0.96 LMNA (0.39) LMNAADH1BADH1CADH1AADH4
SCHEMBL18613557 0.96 LMNA (0.43) LMNAADH1BADH1CADH1AADH4
SCHEMBL27781256 0.94 LMNA (0.42) LMNAADH1BADH1CADH1AADH4
SCHEMBL3030456 0.92 CYP3A4 (0.48) LMNAADH1BADH1CADH1AADH4
Cyclohexane SCHEMBL28005770 0.91 LMNA (0.35) LMNAADH1BADH1CADH1AADH4
SCHEMBL22627187 0.91 TSHR (0.57) LMNAADH1BADH1CADH1AADH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0637318-B1 PEPTIDE DERIVATIVES CORRESPONDING TO THE CARBOXY TERMINAL SEQUENCE OF HIRUDIN CIBA GEIGY AG (CH) 1998-04-01 EP disclosed
US-5686564-A Peptide derivatives corresponding to the carboxy terminal sequence of hirudin NOVARTIS CORPORATION (US) 1997-11-11 US disclosed
EP-0693081-A1 CYCLIC COMPOUNDS AND COMPOSITIONS WHICH INHIBIT BONE RESORPTION Novartis AG (CH) 1996-01-24 EP disclosed
EP-0637318-A1 PEPTIDE DERIVATIVES CORRESPONDING TO THE CARBOXY TERMINAL SEQUENCE OF HIRUDIN Novartis AG (CH) 1995-02-08 EP disclosed
WO-1994024153-A1 CYCLIC COMPOUNDS AND COMPOSITIONS WHICH INHIBIT BONE RESORPTION CIBA-GEIGY AG (CH) 1994-10-27 WO disclosed
US-5354843-A Flanking peptides of calcitonin and processes for their manufacture CIBA-GEIGY CORPORATION (US) 1994-10-11 US disclosed
WO-1993022344-A1 PEPTIDE DERIVATIVES CORRESPONDING TO THE CARBOXY TERMINAL SEQUENCE OF HIRUDIN CIBA-GEIGY AG (CH) 1993-11-11 WO disclosed
EP-0356395-A2 Flanking peptides and process for their preparation CIBA-GEIGY AG (CH) 1990-02-28 EP disclosed